162 related articles for article (PubMed ID: 25973087)
1. Expression of heat-shock protein gp96 in gallbladder cancer and its prognostic clinical significance.
Chen Y; Chen C; Ma C; Sun S; Zhang J; Sun Y
Int J Clin Exp Pathol; 2015; 8(2):1946-53. PubMed ID: 25973087
[TBL] [Abstract][Full Text] [Related]
2. Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.
Xiong L; Deng X; Wen Y; Yang Z; Miao X
World J Surg Oncol; 2013 Mar; 11():80. PubMed ID: 23531103
[TBL] [Abstract][Full Text] [Related]
3. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
Xiong L; Yang Z; Yang L; Liu J; Miao X
J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153
[TBL] [Abstract][Full Text] [Related]
4. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma.
Yuan LW; Liu DC; Yang ZL
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder.
Zou Q; Xiong L; Yang Z; Lv F; Yang L; Miao X
World J Surg Oncol; 2012 May; 10():92. PubMed ID: 22613496
[TBL] [Abstract][Full Text] [Related]
6. Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder.
Yang L; Lan S; Liu J; Yang Z
Diagn Pathol; 2011 Oct; 6():100. PubMed ID: 22018336
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder.
Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY
Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
Shu GS; Lv F; Yang ZL; Miao XY
Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
Jiang S; Pei L; Yang ZL; Liu G
Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16 protein in gallbladder carcinoma and its precancerous conditions.
Choi HJ; Yun SS; Kim HJ; Choi JH
Hepatogastroenterology; 2010; 57(97):18-21. PubMed ID: 20422865
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.
Kim HS; Kim GY; Lim SJ; Park YK; Kim YW
Hum Pathol; 2010 Nov; 41(11):1609-16. PubMed ID: 20688353
[TBL] [Abstract][Full Text] [Related]
12. BRMS1 and HPA as Progression, Clinical Biological Behaviors, and Poor Prognosis-related Biomarkers for Gallbladder Adenocarcinoma.
Yang Z; Liu F; Yang ZL
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):275-82. PubMed ID: 26200836
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
Liu DC; Yang ZL
Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.
Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X
Tumori; 2014; 100(6):667-74. PubMed ID: 25688501
[TBL] [Abstract][Full Text] [Related]
15. Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.
Li Q; Yang Z
J Exp Clin Cancer Res; 2009 May; 28(1):65. PubMed ID: 19445727
[TBL] [Abstract][Full Text] [Related]
16. Expression of CDX2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome.
Li QL; Yang ZL; Liu JQ; Miao XY
Pathol Oncol Res; 2011 Sep; 17(3):561-8. PubMed ID: 21221877
[TBL] [Abstract][Full Text] [Related]
17. Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Liu DC; Yang ZL; Jiang S
Cancer Biomark; 2010-2011; 8(3):113-21. PubMed ID: 22012766
[TBL] [Abstract][Full Text] [Related]
18. Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.
Xu LN; Zou SQ; Wang JM
World J Gastroenterol; 2005 Jun; 11(24):3719-23. PubMed ID: 15968727
[TBL] [Abstract][Full Text] [Related]
19. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder].
Liu DC; Yang ZL
Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance.
Cai W; Li Q; Yang Z; Miao X; Wen Y; Huang S; Ouyang J
Clin Transl Oncol; 2013 Oct; 15(10):818-24. PubMed ID: 23475628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
